OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Improving these processes involves modifying various variables, including cell line engineering, media ingredients, and bioreactor settings. A key goal is to increase antibody yield while reducing production expenses